Fuse Medical Company Top Management
| FZMD Stock | USD 0.05 0.03 150.00% |
Fuse Medical employs about 14 people. The company is managed by 3 executives with a total tenure of roughly 16 years, averaging almost 5.0 years of service per executive, having 4.67 employees per reported executive. Evaluation of Fuse Medical's management performance can provide insight into the firm performance.
| Christopher Reeg CEO CEO, Director |
| Mark Brooks Chairman Chairman of the Board |
Fuse |
Fuse Medical Management Team Effectiveness
The company has return on total asset (ROA) of (0.0331) % which means that it has lost $0.0331 on every $100 spent on assets. This is way below average. Fuse Medical's management efficiency ratios could be used to measure how well Fuse Medical manages its routine affairs as well as how well it operates its assets and liabilities.Fuse Medical holds a total of 72.9 Million outstanding shares. Fuse Medical shows majority of its outstanding shares owned by insiders. An insider is usually defined as a corporate executive, director, member of the board or institutional investor who own at least 10% of the company's outstanding shares. 88.44 percent of Fuse Medical outstanding shares that are owned by insiders denotes they have been buying or selling the stock in recent months in anticipation of some upcoming event. Please note that no matter how many assets the company secures, if the real value of the firm is less than the current market value, you may not be able to make money on it.
Some institutional investors establish a significant position in pink sheets such as Fuse Medical in order to find ways to drive up its value. Retail investors, on the other hand, need to know that institutional holders can own millions of shares of Fuse Medical, and when they decide to sell, the pink sheet will often sell-off, which may instantly impact shareholders' value. So, traders who get in early or near the beginning of the institutional investor's buying cycle could potentially generate profits.
Fuse Medical Workforce Comparison
Fuse Medical is rated below average in number of employees category among its peers. The total workforce of Health Care industry is currently estimated at about 1,060. Fuse Medical claims roughly 14.0 in number of employees contributing just under 2% to equities under Health Care industry.
The company has Profit Margin (PM) of (0.04) %, which may suggest that it does not properly executes on its current pricing strategies or is unable to control all of the operational costs. This is way below average. Similarly, it shows Operating Margin (OM) of (0.05) %, which suggests for every $100 dollars of sales, it generated a net operating loss of $0.05. Fuse Medical Benchmark Summation
Operator |
The output start index for this execution was zero with a total number of output elements of sixty-one. Fuse Medical Price Series Summation is a cross summation of Fuse Medical price series and its benchmark/peer.
Fuse Medical Notable Stakeholders
A Fuse Medical stakeholder refers to an individual interested in an outcome of the business. Different stakeholders have different interests, and companies such as Fuse Medical often face trade-offs trying to please all of them. Fuse Medical's stakeholders can have a positive or negative influence on the entity's direction, and there are a lot of executives involved in getting Fuse Medical's stock to the level that pleases all shareholders. Keeping track of the stakeholders is a great way to stay on top of things affecting its ongoing price.
| Christopher Reeg | CEO, Director | Profile | |
| Mark Brooks | Chairman of the Board | Profile | |
| Lawrence Yellin | Treasurer CFO | Profile |
About Fuse Medical Management Performance
The success or failure of an entity such as Fuse Medical often depends on how effective the management is. Fuse Medical management team is responsible for propelling the future growth in the right direction and administering and controlling the business activities and accounting for the results. Ineffective management usually contributes to failure in the company's future performance for all stakeholders equally, but most importantly, for investors. So it is important to measure the effectiveness of Fuse management before purchasing its stock. In many ways, it's all about finding the answer to one important question - Are they doing the right thing right now? How would we assess whether the Fuse management is utilizing all available resources in the best possible way? Also, how well is the company doing relative to others in its sector and the market as a whole? The answer can be found by analyzing a few important fundamental indicators such as return on assets and return on equity.
Fuse Medical, Inc. manufactures and distributes medical device implants in the United States. The company serves hospitals, medical facilities, and sub-distributors. Fuse Medical operates under Medical Devices classification in the United States and is traded on OTC Exchange.
Please note, the presentation of Fuse Medical's financial position, as portrayed in its financial statements, is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Fuse Medical's management is honest, while the outside auditors are strict and uncompromising. Please utilize our Beneish M Score to check the likelihood of Fuse Medical's management manipulating its earnings.
Fuse Medical Workforce Analysis
Traditionally, organizations such as Fuse Medical use manpower efficiency calculations for various incentive schemes, employee appraisal, or as an initiative to improve the processes. However, it can also be used by investors to make long-term investment decisions. The trends in the profit per employee or revenue per employee are measured by net income or revenue divided by the current number of full-time employees over a given time interval. Because workforce needs differ across sectors, these ratios could be used to compare Fuse Medical within its industry.Fuse Medical Manpower Efficiency
Return on Fuse Medical Manpower
| Revenue Per Employee | 1.5M | |
| Revenue Per Executive | 6.8M | |
| Net Loss Per Employee | 113.4K | |
| Net Loss Per Executive | 529.3K | |
| Working Capital Per Employee | 165K | |
| Working Capital Per Executive | 770.1K |
Complementary Tools for Fuse Pink Sheet analysis
When running Fuse Medical's price analysis, check to measure Fuse Medical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Fuse Medical is operating at the current time. Most of Fuse Medical's value examination focuses on studying past and present price action to predict the probability of Fuse Medical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Fuse Medical's price. Additionally, you may evaluate how the addition of Fuse Medical to your portfolios can decrease your overall portfolio volatility.
| Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges | |
| USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA | |
| AI Portfolio Prophet Use AI to generate optimal portfolios and find profitable investment opportunities | |
| Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
| Equity Valuation Check real value of public entities based on technical and fundamental data | |
| Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets |